Fund Holdings — Caligan Partners LP

Total Portfolio Value:
$1.09B
Total Bought:
$297.02M
Total Sold:
$92.65M
Net Transaction:
+$204.37M
Notable People:
Caligan Partners Gp Llc
Securities
▲▼
SharesValue
Q3 2025
▲▼
Q4 2025
▲▼
Change
▲▼
Q3 2025
▲▼
Q4 2025
▲▼
Weight (%)
▲▼
Change
▲▼
Liquidia Corporation(LQDA)8,118,8928,118,8920$184.62M$280.02M25.63%+$95.40M
ABIVAX Société AnonymeADS(ABVX)1,451,9241,451,9240$123.27M$195.80M17.92%+$72.53M
Revolution Medicines, Inc.(RVMD)1,064,2491,283,900+219,651$49.70M$102.26M9.36%+$52.56M
Mineralys Therapeutics, Inc.(MLYS)2,772,6542,772,6540$105.14M$100.62M9.21%-$4.52M
Vaxcyte, Inc.(PCVX)01,704,815+1,704,815$0$78.66M7.20%+$78.66M
Exelixis, Inc.(EXEL)1,525,7301,553,262+27,532$63.01M$68.08M6.23%+$5.07M
Adma Biologics Inc2,636,6093,012,508+375,899$38.65M$54.95M5.03%+$16.30M
Tango Therapeutics, Inc.(TNGX)03,729,895+3,729,895$0$33.05M3.03%+$33.05M
Inhibrx Biosciences, Inc.(INBX)236,383323,565+87,182$7.96M$25.56M2.34%+$17.60M
Tyra Biosciences, Inc.(TYRA)696,825944,257+247,432$9.75M$24.82M2.27%+$15.08M
Xenon Pharmaceuticals Inc.(XENE)444,565549,665+105,100$17.85M$24.64M2.26%+$6.79M
Maze Therapeutics, Inc.(MAZE)0550,191+550,191$0$22.79M2.09%+$22.79M
Rapt Therapeutics Inc0644,400+644,400$0$21.83M2.00%+$21.83M
Avalo Therapeutics, Inc.(AVTX)833,333881,533+48,200$10.59M$16.01M1.47%+$5.42M
Anika Therapeutics Inc1,435,1301,435,1300$13.49M$13.79M1.26%+$301.4K
Vor Biopharma Inc.(VOR)0925,067+925,067$0$9.96M0.91%+$9.96M
Inventiva S.A.ADS(IVA)02,000,000+2,000,000$0$9.30M0.85%+$9.30M
Verrica Pharmaceuticals Inc.(VRCA)923,910923,9100$3.98M$7.68M0.70%+$3.70M
Spruce Biosciences Inc020,514+20,514$0$1.79M0.16%+$1.79M
Eledon Pharmaceuticals, Inc.(ELDN)0555,978+555,978$0$839.5K0.08%+$839.5K
Agios Pharmaceuticals, Inc.(AGIO)1,131,2050-1,131,205$45.41M$0—-$45.41M
Aura Biosciences, Inc.(AURA)227,1740-227,174$1.40M$0—-$1.40M
Evolus, Inc.(EOLS)4,138,9430-4,138,943$25.41M$0—-$25.41M
Merus N V216,9540-216,954$20.43M$0—-$20.43M
Page 1 of 1
Caligan Partners LP — 13F Holdings — Q4 2025 | TickerTrail